QT Vascular, a provider of advanced therapeutic solutions, said it had received "indications of interest" in relation to a potential transaction relating its assets.
Shares in the company, which develops technologies for the treatment of peripheral artery disease and coronary vascular disease, rose as much as 18 percent to S$0.013.
QT Vascular will continue to engage with the potential parties for the potential transaction, and will continue to pursue opportunities which are of interest and benefit to the company, it said in a statement on Sunday.
Singapore-based firm said the indications of interest are not legally binding and not definitive. The negotiations were first announced in May this year.
It did not disclose the details of the potential transaction or people it was in talks with.
QT Vascular said it aims to continue to generate value for shareholders from its mature products while further developing and commercializing its drug coated products.
At 0211 GMT, shares in the company were trading up 9 percent to S$0.012 on the Singapore Exchange. The stock has slumped 85 percent so far this year.